Events

The SBIR/STTR Reauthorization bill is official, and there are new changes to be aware of. Attend this upcoming webinar to learn more about those changes, the application process, and to get the latest on timing and program updates.

Kirk Macolini of InteliSpark will lead a free virtual workshop on the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process.

You will learn:

• How to craft a successful SBIR/STTR application
• Strategies for developing a competitive proposal
• Find out the latest news about the SBIR/STTR program

Register here. 

Please mark your calendars for this year’s BioInnovate Program Series celebrating life science innovators from Weill Cornell Medicine as well as startup representatives from Cornell University and Cornell Tech.

Join leading investors and industry representatives from organizations including Healthwrx, EpiVax, Fusion Fund, LabyRx, Scion Life Sciences, L.E.K. Consulting, Qiming Venture Partners, and Regeneron for a dynamic series of conversations and events.

This panel of leading life sciences investors and industry representatives will share practical guidance on how academic innovators and spinout teams can strategically engage with potential funders and corporate development partners. The discussion will focus on the intentional steps founders take to secure and maximize high-value interactions with investors and industry, including how to build visibility, credibility, and relationship status.

Register here. 

Join us for a fireside chat featuring Jennifer Tegan, Managing Director of New York Ventures for Empire State Development. In conversation with a Cornell Entrepreneur in Residence, Jennifer will explore how New York State strengthens its entrepreneurial ecosystem by expanding access to venture capital and supporting high-growth companies. 

Whether you’re a founder, investor, or ecosystem builder, this conversation offers valuable insight into how public investment supports startup growth across the state. 

Register here. 

Participate in a free, month-long I-Corps Regional Course to receive expert guidance as you evaluate the market potential of your deep technology innovation. You’ll gain a deeper understanding of your field and learn valuable professional skills in the process. 

In this conference course (May 11 - June 5), a select group of researchers working on oncology technology will "get out of their comfort zone" and talk to customers at the American Society of Clinical Oncology (ASCO) Annual Meeting to identify the best product-market fit. The course begins online and culminates with a trip to Chicago, IL for the 2026 ASCO Annual Meeting. Up to $5,000 (depending on team size) in travel reimbursement funding will be available for accepted teams*.   

You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework. 

Apply here. Applications will be reviewed on a rolling basis. Please contact icorps@cornell.edu for any questions. 

Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.  

Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Shannon Collins and program alum Paola Calderon will be in attendance to share their experience and answer questions.  

The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.   

Register here.  

You’re invited to the Future of Care Conference 2026. This year's theme "One Size Fits None" captures a new vision for healthcare: medicine designed around the individual, not the average.

Together, we will explore how emerging technologies, artificial intelligence, and innovative care models are redefining the future of personalized medicine. Our conference will bring together an interdisciplinary community of students, clinicians, researchers, entrepreneurs, and industry leaders to share ideas and showcase innovations that are transforming patient care. Throughout the day, attendees will engage with inspiring speakers and thought-provoking conversations centered around advancing more precise, patient-centered healthcare.

Learn more and RSVP at futureofcare.nyc. 

Please mark your calendars for this year’s BioInnovate Program Series celebrating life science innovators from Weill Cornell Medicine as well as startup representatives from Cornell University and Cornell Tech.

Join leading investors and industry representatives from organizations including Healthwrx, EpiVax, Fusion Fund, LabyRx, Scion Life Sciences, L.E.K. Consulting, Qiming Venture Partners, and Regeneron for a dynamic series of conversations and events.

With more than 21,000 drug programs in the global R&D pipeline, you might expect a surge in new biological targets. Instead, novel targets entering development have fallen from ~100 per year a decade ago to about 30 in 2024, while 25% of drug-target pairs focus on just 38 well-known targets.

As AI, new modalities, and cell therapies expand the frontier of drug discovery, what does it take to build the chain of evidence investors and industry partners need to back a novel target? Join our upcoming panel to find out.

Register here. 

Building a startup means understanding your legal obligations as an employer from day one. 

 Join us for an Entrepreneurship Essentials workshop focused on worker’s compensation, where we’ll break down what founders need to know to protect their teams and their businesses. This session will cover when coverage is required, how policies work, common misconceptions, and what steps to take if a workplace injury occurs. 

Whether you’re preparing to hire your first employee or already growing your team, this workshop will provide practical guidance to help you stay compliant, minimize risk, and build a strong operational foundation. 

RSVP today to ensure your startup is set up for success! 

Why does health IT still frustrate so many healthcare stakeholders? Why were early systems designed with limited clinician input? Can AI help fix the problems created by legacy systems?

You’re invited to join us for a conversation with Dr. S. Yin Ho, author of Rushing Headlong: Health IT’s Legacy and the Road to Responsible AI. 

In her new book, Dr. Ho examines how the early architecture of health information technology shaped the systems that clinicians and researchers struggle with today. As generative AI arrives, those same structural choices may determine whether AI ultimately better serves practitioners and patients or simply adds another layer of complexity.

Dr. Ho is a serial entrepreneur and visionary executive in health IT and clinical research with more than 25 years of experience founding, building, and leading healthcare technology companies and initiatives.  Most recently, she served as Interim CEO of Veradigm, where she led the strategic acquisition of generative AI company ScienceIO. Under her leadership, Veradigm became the first electronic health record company to develop proprietary small language models in-house—an effort aimed at improving the quality of clinical data used for both care and research.

Join us for a candid discussion about the past, present, and future of health IT.  Register here.

During this webinar, we will explore the role of business development and partnering in helping advance life sciences innovation from the lab to the marketplace. Through a discussion with our seasoned panelists, we will compare the business development objectives and strategies across different ecosystem partners (venture capital, biotech and pharma) and the role (and goals) of academic partnerships.

Register here.